“…Pharmacological studies in the past decade have shown that polydatin exhibits a broad range of bioactivities with cardiovascular relevance, including antioxidation, anti-inflammation, cardioprotection, blood vessel dilation, lipid-lowering effect, as well as inhibitory effects on platelet aggregation, monocyte adhesion to activated endothelium, thrombus formation, and atherosclerosis development (Du et al, 2009;Deng et al, 2011;Liu et al, 2012b;Ma et al, 2016;Gugliandolo et al, 2017). The preventive effects of polydatin on foam cell formation were reported recently (Wu et al, 2015b). Polydatin treatment of 48 hours reduced the level of TC, FC, and CE, together with reducing the secretion of TNF-a and IL-1b in oxLDL-stimulated ApoE 2/2 mouse macrophages.…”